DAC Patient Recruitment Debuts Updated DACTracks Clinical Trial Metrics Software
As a clinical trial sponsor, being able to measure research programs with pinpoint accuracy is a valuable proposition.
As a clinical trial sponsor, being able to measure research programs with pinpoint accuracy is a valuable proposition. That's precisely what DAC Patient Recruitment Services (DAC), an Imperial company and a leader in clinical trial patient recruitment and retention, offers through its proprietary DACTracks™ technology.
"Evaluating real-time program data is essential in analyzing return on investment," said DAC Vice President of Operations Melynda Geurts. "That is why DAC created DACTracks. This active, online reporting system keeps valuable program data at our clients' fingertips."
Sponsors will enjoy 24-hour access to reports on their research sites' screenings, referrals, randomizations (projected and actual), enrollment, attrition, and more. Both site-specific and global data are available. Impact graphs map recruitment trends following the launch of specific initiatives, and charts display the number of aggregate and site-specific referrals color-coded by source. The retention page features the total number of active and non-active subjects in the study and a summary of discontinued subjects, including reasons for discontinuation.
DACTracks also provides comprehensive statistics on study website performance, including unique site visitors, page views, online pre-qualification, and web traffic sources. Regarding the latter, users will be able to discern at the click of a mouse whether web traffic originated from search engines, referring sites or direct traffic to the study website URL.
For more information about DACTracks, and to sign up for a free demonstration, visit www.imperialcrs.com/dac/dactracks or write to [email protected]
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
